van den Berg H - Search Results

1

Gene expression profile of slowly responding subclones might represent different profiles already at diagnosis and might be used for prediction of outcome.

de Haas V, Dee R, Cheroutre G, van den Berg H, van der Schoot CE. de Haas V, et al. Among authors: van den berg h, van der schoot ce. Leukemia. 2009 Apr;23(4):816-9. doi: 10.1038/leu.2008.315. Epub 2008 Nov 6. Leukemia. 2009. PMID: 18987656 No abstract available.

2

Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, Slater RM, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1995 Oct;9(10):1726-34. Leukemia. 1995. PMID: 7564517

3

IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL.

Steenbergen EJ, Verhagen OJ, van Leeuwen EF, van den Berg H, Behrendt H, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1995 Jan;9(1):216-22. Leukemia. 1995. PMID: 7845021

4

A young child with acquired t(8;9)(p11;q34): additional proof that 8p11 is involved in mixed myeloid/T lymphoid malignancies.

van den Berg H, Kroes W, van der Schoot CE, Dee R, Pals ST, Bouts TH, Slater RM. van den Berg H, et al. Among authors: van der schoot ce. Leukemia. 1996 Jul;10(7):1252-3. Leukemia. 1996. PMID: 8684012 No abstract available.

5

Clonal evolution of immunoglobulin heavy chain rearrangements in childhood B-precursor acute lymphoblastic leukemia after engraftment in SCID mice.

Steenbergen EJ, Verhagen OJ, Nibbering CP, van den Berg H, van Leeuwen EF, Behrendt H, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1996 Sep;10(9):1471-8. Leukemia. 1996. PMID: 8751465

6

Rearrangement status of the malignant cell determines type of secondary IgH rearrangement (V-replacement or V to DJ joining) in childhood B precursor acute lymphoblastic leukemia.

Steenbergen EJ, Verhagen OJ, van den Berg H, van Leeuwen EF, Behrendt H, Slater RR, von dem Borne AE, van der Schoot CE. Steenbergen EJ, et al. Among authors: van den berg h, van der schoot ce, van leeuwen ef. Leukemia. 1997 Aug;11(8):1258-65. doi: 10.1038/sj.leu.2400720. Leukemia. 1997. PMID: 9264379

7

Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy.

de Haas V, Verhagen OJ, von dem Borne AE, Kroes W, van den Berg H, van der Schoot CE. de Haas V, et al. Among authors: van den berg h, van der schoot ce. Leukemia. 2001 Jan;15(1):134-40. doi: 10.1038/sj.leu.2401970. Leukemia. 2001. PMID: 11243381

8

Bidirectional differentiation involving a cell with rearrangement of the MLL gene.

van den Berg H, Caron HN, Theunissen PH, Theunissen PM, van der Schoot CE, Kroes W, Beverloo HB, Slater R. van den Berg H, et al. Among authors: van der schoot ce. Leukemia. 1998 Jan;12(1):102-3. doi: 10.1038/sj.leu.2400899. Leukemia. 1998. PMID: 9436928 No abstract available.

9

Minimal residual disease studies are beneficial in the follow-up of TEL/AML1 patients with B-precursor acute lymphoblastic leukaemia.

de Haas V, Oosten L, Dee R, Verhagen OJ, Kroes W, van den Berg H, van der Schoot CE. de Haas V, et al. Among authors: van den berg h, van der schoot ce. Br J Haematol. 2000 Dec;111(4):1080-6. doi: 10.1046/j.1365-2141.2000.02434.x. Br J Haematol. 2000. PMID: 11167743 Free article.

10

Risk assessment in ALL in children: a focus on PCR-based techniques for MRD detection.

de Haas V, van der Schoot CE, van den Berg H. de Haas V, et al. Among authors: van den berg h, van der schoot ce. Ann Oncol. 2001 May;12(5):587-92. doi: 10.1023/a:1011165510924. Ann Oncol. 2001. PMID: 11432614 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

789 results

Search Page